Home › Hemophilia B › Indiana › Indianapolis
Hemophilia B clinical trials in Indianapolis, IN
3 studies for Hemophilia B are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
RecruitingPhase 3
- Innovative Hematology, Inc., Indianapolis
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
RecruitingPhase 1/2
- Indiana Hemophilia and Thrombosis Center, Indianapolis
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Indiana Hemophilia and Thrombosis Center, Indianapolis
Hemophilia B trials in other cities
- Philadelphia, PA5 studies
- Sacramento, CA4 studies
- Los Angeles, CA4 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- Ann Arbor, MI4 studies
- San Francisco, CA3 studies
- Seattle, WA3 studies
- Greenville, NC3 studies
- Nashville, TN3 studies
- Gainesville, FL3 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Obesity20 studies
- Breast Cancer20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Cardiovascular Disease17 studies
- Lung Cancer16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.